Autolus Therapeutics PLC (NASDAQ:AUTL)
| 4.28 Delayed Data As of Nov 30 |  +0.195 / +4.78%Today’s Change | 1.60 Today|||52-Week Range 4.83 | +125.00% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | -- | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | -- | -- |
| Depreciation And Amortization | 476.2K | 1.0M | 1.7M | -- | ||
| Operating Expenses | Gross Income | -476.2K | -1.0M | -1.7M | -- | |
| General Expenses | 15.1M | 24.2M | 57.4M | -- | ||
| Research And Development | 10.4M | 16.1M | 36.3M | -- | ||
| Total Operating Expenses | 15.5M | 25.3M | 59.1M | -- | ||
| Non-Operating Expenses | Operating Income | -15.5M | -25.3M | -59.1M | -- | |
| Other Expenses | 1.2M | 1.7M | 5.4M | -- | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -14.3M | -23.5M | -52.2M | -- | |
| Income Taxes | -1.8M | -3.7M | -7.3M | -- | ||
| Net Income | -12.5M | -19.8M | -44.9M | -- | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 40.1M | 40.1M | 31.6M | -- | |
| Shares To Calculate EPS Diluted | 40.1M | 40.1M | 31.6M | -- | ||
| Earnings Per Share | EPS | -$0.31 | -$0.49 | -$1.42 | -- | |
| EPS Diluted | -$0.31 | -$0.49 | -$1.42 | -- | ||
